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156In-hospital versus postdischarge adverse events
following carotid endarterectomy
Margriet Fokkema, MD,a,b Rodney P. Bensley, MD,a Ruby C. Lo, MD,a Allan D. Hamden, MD,a
Mark C. Wyers, MD,a Frans L. Moll, MD, PhD,b Gert Jan de Borst, MD, PhD,b and
Marc L. Schermerhorn, MD,a Boston, Mass; and Utrecht, The Netherlands
Objective: Most studies based on state and nationwide registries evaluating perioperative outcome after carotid endar-
terectomy (CEA) rely on hospital discharge data only. Therefore, the true 30-day complication risk after carotid revas-
cularization may be underestimated.
Methods:We used the National Surgical Quality Improvement Program database 2005-2010 to assess the in-hospital and
postdischarge rate of any stroke, death, cardiac event (new Q-wave myocardial infarction or cardiac arrest), and
combined stroke/death and combined adverse outcome (S/D/CE) at 30 days following CEA. Multivariable analyses
were used to identify predictors for in-hospital and postdischarge events separately, and in particular, those that predict
postdischarge events distinctly.
Results: A total of 35,916 patients who underwent CEA during 2005-2010 were identiﬁed in the National Surgical
Quality Improvement Program database; 59% were male, median age was 72 years, and 44% had a previous neurologic
event. Thirty-day stroke rate was 1.6% (n[ 591), death rate was 0.8% (n[ 272), cardiac event rate was 1.0% (n[ 350),
stroke or death rate was 2.2% (n [ 794), and combined S/D/CE rate was 2.9% (n [ 1043); 33% of strokes, 53% of
deaths, 32% of cardiac events, 40% of combined stroke/death, and 38% of combined S/D/CE took place after hospital
discharge. Patients with a prior stroke or transient ischemic attack had similar proportions of postdischarge events
compared with patients without prior symptoms. Independent predictors for postdischarge events, but not for in-
hospital events were female sex (stroke [odds ratio (OR), 1.6; 95% conﬁdence interval (CI), 1.2-2.1] and stroke/death
[OR, 1.4; 95% CI, 1.1-1.7]), renal failure (stroke [OR, 3.0; 95% CI, 1.4-6.2]) and chronic obstructive pulmonary disease
(death [OR, 2.5; 95% CI, 1.6-3.7], stroke/death [OR, 1.8; 95% CI, 1.4-2.4], and S/D/CE [OR 1.8, 95% CI 1.4-2.3]).
Conclusions: With 38% of perioperative adverse events after CEA happening posthospitalization, regardless of symptoms
status, we need to be alert to the ongoing risks after discharge particularly in women, patients with renal failure, or
chronic obstructive pulmonary disease. This emphasizes the need for reporting and comparing 30-day adverse event rates
when evaluating outcomes for CEA, or comparing carotid stenting to CEA. (J Vasc Surg 2013;57:1568-75.)The beneﬁt of carotid endarterectomy (CEA) and
carotid angioplasty and stenting (CAS) is highly inﬂuenced
by the rate of perioperative adverse events, deﬁned as
stroke, myocardial infarction (MI), or mortality up to
30 days after the procedure. Many studies reporting and
comparing perioperative complication rates following
carotid revascularization rely on state and nation-wide
registries, which only include in-hospital data.1-3 How-
ever, procedure-related complications and mortality afterthe Department of Vascular Surgery, Beth Israel Deaconess Medical
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8revascularization procedures might also take place after
hospital discharge. Results from the Society for Vascular
Surgery Vascular Registry suggest that in-hospital events
do not reﬂect the full procedural event rate after CAS and
CEA, as an additional 31% and 22% of combined adverse
events, respectively, occurred after discharge from the
hospital.4 However, in that analysis, less than 50% of the
total patients completed 30-day follow-up, and thus, these
estimates may under- or overestimate the true event rates.
Others have suggested that 10% to 37% of strokes took
place after discharge, but these studies are limited by small
study size or incomplete follow-up.5,6 Also, these analyses
did not include adverse outcomes after CEA other than
stroke. To compare and evaluate outcomes of CEA and
CAS, it seems crucial to report 30-day outcome. For
patients, it is important to understand the true operative
risk they are facing when deciding whether to undergo
CEA. Those patients who are at high risk to develop
procedural-related events after discharge might beneﬁt
from closer surveillance after discharge and possibly changes
in management. Different preoperative patient characteris-
tics may be related to the timing of events. Our objective
was to assess the in-hospital and postdischarge rate of
adverse events following CEA in a 100% follow-up cohort
at 30 days and to identify independent predictors for the
timing of these events.
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Database. Data were obtained from medical records of
patients undergoing CEA between 2005 and 2010 in the
American College of Surgeon’s National Surgical Quality
Improvement Program (NSQIP) database. The NSQIP is
a multicenter, prospective quality-improvement registry
that includes academic and private US hospitals. In 2005,
37 institutions participated in the program, and the
number has increased to 258 by 2010. Demographics,
preoperative risk factors, intraoperative variables, and 30-
day postoperative mortality and morbidity outcomes are
collected, validated, and submitted by a trained and audi-
ted surgical clinical nurse-reviewer designated by the
American College of Surgeon. No speciﬁc procedural
information on CEA (such as reconstruction technique,
shunt use, type of artery closure, or neurologic monitoring)
is captured by the current iteration of NSQIP. Postsurgical
data are obtained for the entire 30-day time period,
regardless of whether the patient is discharged to the
outpatient setting before this time. A detailed description
of the NSQIP study methods has been previously pub-
lished and validated.7 The NSQIP data are subject to
annual auditing, and the reliability of accurate data acqui-
sition has improved with each year.8
Patient selection. The NSQIP database was queried
to identify patients undergoing CEA between 2005 and
2010 using the Current Procedural Terminology codes
35301 and 35390. Cases were selected in which CEA
was the primary procedure. Patients undergoing concur-
rent cardiac surgery were excluded. The remaining proce-
dure data were searched to ensure that no other major
procedure was included. Indication for surgery (symptom
status and degree of stenosis) is not available in the data-
base. Therefore, we were not able to formally stratify
patients by symptom status. However, NSQIP captures
a history of a previous neurologic event (stroke, transient
ischemic attack [TIA]) and hemiplegia, without the timing
and laterality of these events. This variable was used to
distinguish patients who were clearly asymptomatic (ASX)
from those who had previous neurologic symptoms
(SXS). Recent work from our group showed that those
with prior SXS were most likely to be symptomatic.9
Endpoints and measurements. Our primary end-
point was the development of stroke, death, or a cardiac
event within 30 days after CEA. Stroke was deﬁned as
the development of an embolic, thrombotic, or hemor-
rhagic vascular accident or stroke with motor, sensory,
or cognitive dysfunction (eg, hemiplegia, hemiparesis,
aphasia, sensory deﬁcit, impaired memory) that persists
for 24 or more hours. A cardiac event was deﬁned as
a new Q-wave MI on electrocardiogram or cardiac arrest
that necessitated cardiopulmonary resuscitation. Our
secondary endpoint was wound infection, deﬁned as either
involving the carotid artery, deep (involving deep soft
tissue’s eg, fascia and muscle layers of the incision) or
a superﬁcial surgical site infection (limited to skin and
subcutaneous).Results were stratiﬁed for the in-hospital period (intra-
operative or predischarge) and the postdischarge period
through 30-days after surgery. Timing to adverse event
was recorded per day, starting from the day of surgery
(day 0). The proportion of postdischarge events was
analyzed for both patients with a history of neurologic
symptoms and patients without a history of neurologic
symptoms. For in-hospital analysis, patients with post-
discharge events were excluded. Likewise, for post-
discharge events, patients with in-hospital events were
excluded. If patients suffered both in-hospital and post-
discharge events, the in-hospital event was counted for
analysis. Predictor variables for the primary outcome
included demographics and preoperative variables. Contin-
uous variables were categorized for the purpose of this
study. Detailed deﬁnitions of these variables are listed in
the Appendix (online only).
Statistical analysis. Bivariate analysis was carried out
to assess the relation of the preoperative variables with
the primary outcome (stroke, death, cardiac event or
a composite of stroke/death and S/D/CE) at the different
time points (in-hospital, postdischarge, 30-day) using
Pearson c2 test and Fisher exact test. Initial bivariate
analysis included 29 preoperative demographic and co-
morbidity variables. Multivariable logistic regression was
used to assess independent risk factors for outcome events
at each of the above speciﬁed time points. Demographics
and preoperative variables were entered into the multi-
variable regression analysis if P < .2 in bivariate analysis.
Associations were calculated using backward elimination
procedure, in which all variables were entered in the ﬁrst
step and removed stepwise based on the highest non-
signiﬁcant P value (P $ .05). After carrying out this
iterative process, covariates were included in the ﬁnal
model if predictive of primary outcome events in any of
the three speciﬁed clinical time intervals with this model
demonstrating the contribution of each covariate to
timing of events. Odds ratios (ORs) with 95% conﬁdence
intervals (CIs) were reported. Hosmer and Lemeshow
test was used to test the goodness of ﬁt in each model.
Statistical analysis was performed using SPSS v. 19.0
statistical software (SPSS Inc, Chicago, Ill).
RESULTS
A total of 35,916 patients undergoing CEA between
2005 and 2010 in the NSQIP database were identiﬁed and
included for analysis. The median age was 72 years (inter-
quartile range [IQR], 13), 59.1% were men, and 44.1% had
a history of stroke, TIA, or hemiplegia. Demographics, clin-
ical characteristics, and operative details are shown inTable I.
Stroke rate at 30 days was 1.6% (n ¼ 591; prior
neurologic SXS 2.4% vs ASX 1.1%; OR, 2.25; 95% CI,
1.89-2.66; P < .001), death rate was 0.8% (n ¼ 272; prior
neurologic SXS 1.1% vs ASX 0.5%; OR, 2.03; 95% CI,
1.59-2.59; P < .001), and cardiac event rate was 1.0% (n ¼
350; prior neurologic SXS 1.1% vs ASX 0.8%; OR, 1.38;
95% CI, 1.12-1.70; P ¼ .003). Combined stroke/death
Table I. Demographics and clinical characteristics of
35,916 patients undergoing carotid endarterectomy (CEA)
Variable No. or median % or (IQR)
Demographics
Age, years 72 (13)
<60 years 5123 14.4
60-69 years 11,283 31.8
70-80 years 13,226 37.3
>80 years 5871 16.5
Sex
Male 21,184 59.1
Female 14,657 40.9
Race, non-white 3046 8.5
Clinical characteristics
Redo CEA 82 0.2
Hx stroke/hemiplegia 8936 24.9
Hx of TIA 9954 27.7
Hx of angina or MI 1364 3.8
Congestive heart failure 371 1.0
Previous PCI 6710 18.7
Previous cardiac surgery 8196 22.8
Diabetes mellitus 9984 27.8
Hypertension 30,658 85.4
Current smoker 10,033 27.9
Hx of smoking
<10 pack-years 11,161 32.3
10-29 pack-years 4939 13.8
30-49 pack-years 3726 10.4
50-70 pack-years 3517 9.8
>70 pack-years 2921 8.1
Alcohol use >2 drinks/day 1557 4.3
BMI
<18.5 537 1.5
18.5-24.9 9507 26.5
25-29.9 13,814 38.5
30-34.9 7470 20.8
35-40 2687 7.5
$40 1154 3.2
Height
<64 inch 12,040 34.0
64-70 inch 14,750 41.6
>70 inch 8636 24.4
Renal failure 476 1.3
Hx of COPD 3792 10.6
Dyspnea 6847 19.1
Steroid use 747 2.1
Hx of revascularization for PVD 3499 9.7
Rest pain/gangrene 344 1.0
Functional status
Independent 33,952 94.5
Dependent 1961 5.5
Emergency procedure 614 1.7
ASA class >3 4753 13.2
General anesthesia 30,184 84.1
Vascular surgeon 34,019 94.7
PGY level #3 4152 11.6
ASA, American Society of Anesthesiologists; BMI, body mass index; COPD,
chronic obstructive pulmonary disease; Hx, history; IQR, interquartile
range; MI, myocardial infarction; PCI, percutaneous coronary intervention;
PGY, postgraduate year of resident; PVD, peripheral vascular disease; TIA,
transient ischemic attack.
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1.5%;OR, 2.16; 95%CI, 1.87-2.50;P< .001) and combined
S/D/CE rate was 2.9% (n ¼ 1043; prior neurologicSXS 3.9% vs ASX 2.1%; OR, 1.86; 95% CI, 1.64-2.11; P <
.001). Themedian length of hospital stay was 1 day (IQR, 1).
Timing of events. In-hospital S/D/CE occurred in
656 patients (1.8%). After discharge, an additional 38%
of S/D/CE (n ¼ 399; 1.1%) occurred; 33% of strokes
(n ¼ 195; 0.5%), 53% of deaths (n ¼ 144; 0.4%), 32%
of cardiac events (n ¼ 122; 0.3%), and 40% of stroke/
death (n ¼ 320; 0.9%) occurred after discharge. The
proportion of combined S/D/CE after discharge was
similar in patients with prior neurologic symptoms vs those
without (39% and 38%, respectively). Postdischarge,
stroke happened in 34% of patients with prior neurologic
symptoms, and in 32% of ASX patients; 52% of deaths,
31% of cardiac events, and 40% of stroke/death occurred
after discharge in patients with prior neurologic symp-
toms, vs 55% of deaths, 33% of cardiac events, and 40%
of stroke/death in ASX patients (Table II). In-hospital
adverse events happened at a median of 1 day (IQR, 1).
These patients were discharged from the hospital at a
median of 7 days (IQR, 8) postoperatively. Patients who
experienced postdischarge events were discharged at day 1
(median) postoperatively (IQR, 1). Postdischarge stroke
occurred at a median of 8 days after the operation (IQR,
11) (Fig). MI or cardiac arrest (cardiac events) after
discharge took place at a median of 6 days (IQR, 17) and
11 days (IQR, 19), respectively. Patients who survived to
discharge but did not survive the postdischarge period,
died at a median interval of 11 days (IQR, 15).
Thirty-day wound infection rate was 0.5% (n ¼ 197).
The majority of wound infections took place after
discharge: 94% of superﬁcial wound infection (n ¼ 141;
0.4%), 94% of deep wound infection (n ¼ 47; 0.1%) and
89% of carotid infection (n ¼ 9; 0.03%).
Predictors for stroke
In-hospital. Independent predictors for in-hospital
stroke were redo CEA, a history of stroke/hemiplegia,
history of TIA, history of angina/MI, underweight (vs
normal weight) and obesity class II (vs normal weight),
functional dependent status (vs independent), emergency
procedures, and ASA class >3 (Table III).
Postdischarge. History of stoke/hemiplegia, history
of TIA, renal failure, and female sex were associated with
increased risk of postdischarge stroke on multivariable
analyses (Table III). Women were more likely to have
a postdischarge stroke than men (38.1% vs 29.0%; OR,
1.57; 95% CI, 1.18-2.09; P ¼ .002). In patients with
a previous neurologic event, a signiﬁcantly higher stroke rate
was seen in women compared with men (1.0% vs 0.7%; OR,
1.5; 95% CI, 1.1-2.1; P ¼ .02). In ASX patients, the stroke
rate was again higher in women with a similar OR, however,
this did not reach statistical signiﬁcance (0.4% vs 0.3%; OR,
1.6; 95% CI, 0.97-2.5; P ¼ .08). Stroke in woman took
place at a median of 2 days (IQR, 6), compared with 1 day
(IQR, 6) in men (P ¼ .4). Stroke in patients with renal
failure took place at a median of 7 days (IQR, 9) after
discharge, compared with 1 day (IQR, 6) in patients
without renal failure (P < .001). Female gender and renal
Fig. Days from operation until postdischarge stroke after carotid
endarterectomy (CEA). Median days, 8; interquartile range
[IQR], 11.
Table II. Outcome and timing of in-hospital, postdischarge, and 30-day events of 35,916 patients undergoing carotid
endarterectomy (CEA)
Time to event, days
Median,
IQR Mean 6 SD
In-hospital
event rate,
No. (%)
Postdischarge
event rate,
No. (%)
30-day
event rate,
No. (%)
Proportion of events
that occurred
after discharge
All patients
Stroke 1, 6 4.5 6 6.6 396 (1.1) 195 (0.5) 591 (1.6) 33%
Death 8.5, 14 11.2 6 8.6 128 (0.4) 144 (0.4) 272 (0.8) 53%
Cardiac event NA NA 238 (0.7) 112 (0.3) 350 (1.0) 32%
Stroke/death NA NA 480 (1.3) 320 (0.9)a 794 (2.2) 40%
Stroke/death/
cardiac event
NA NA 656 (1.8) 399 (1.1)b 1043 (2.9) 38%
Patients with a prior
neurologic event
Stroke 2, 6 4.6 6 6.4 249 (1.6) 127 (0.8) 376 (2.4) 34%
Death 9, 15 11.8 6 8.7 81 (0.5) 86 (0.5) 167 (1.1) 52%
Cardiac event NA NA 126 (0.8) 56 (0.4) 182 (1.1) 31%
Stroke/death NA NA 302 (1.9) 201 (1.3) 497 (3.1) 40%
Stroke/death/
cardiac event
NA NA 387 (2.4) 238 (1.5) 616 (3.9) 39%
Asymptomatic patients
Stroke 1, 6 4.5 6 6.9 147 (0.7) 68 (0.3) 215 (1.1) 32%
Death 8, 8 10.5 6 8.2 47 (0.2) 58 (0.3) 105 (0.5) 55%
Cardiac event NA NA 112 (0.6) 56 (0.3) 168 (0.8) 33%
Stroke/death NA NA 178 (0.9) 119 (0.6) 297 (1.5) 40%
Stroke/death/
cardiac event
NA NA 269 (1.3) 161 (0.8) 427 (2.1) 38%
IQR, Interquartile range; NA, data not available; SD, standard deviation.
Bold values indicate P < .05.
aSix patients died postdischarge after having an in-hospital stroke.
bTwelve patients experienced a secondary postdischarge event, after having an in-hospital stroke (N ¼ 6) or cardiac event (N ¼ 6).
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multivariable analysis, but not for in-hospital stroke
(Table III).Predictors for stroke or death
In-hospital. In multivariable analysis, age >80 years,
history of stroke/hemiplegia, history of TIA, history of
angina/MI, renal failure, history of revascularization for
peripheral vascular disease (PVD), dependent functional
status, emergency procedures, and ASA class >3 were inde-
pendent predictors for stroke or death (Table IV).
Postdischarge. Female sex, history of stroke/hemi-
plegia, history of angina/MI, renal failure, chronic obstruc-
tive pulmonary disease (COPD) and dependent functional
status were independently associated with postdischarge
stroke or death. Female sex and COPD were predictive
for postdischarge stroke/death, but not for in-hospital
events (Table IV).
Predictors for other adverse events
A history of COPD or dyspnea was predictive for
postdischarge and 30-day death but not for in-hospital
death. (Table V, online only) For cardiac events, no dif-
ferential predictors were identiﬁed in the postdischarge
time period compared with in-hospital time frame
(Table VI, online only). As was seen with death and
stroke/death, patients with a history of COPD were at
increased risk for postdischarge and 30-day combined S/
D/CE but not for in-hospital adverse events (Table VII,
online only). Although the risk factors identiﬁed for
Table III. Independent preoperative predictors for in-hospital, postdischarge, and 30-day stroke
In-hospital Postdischarge 30-day
OR 95% CI P value OR 95% CI P value OR 95% CI P value
Female 1.0 0.8-1.3 .9 1.6 1.2-2.1 <.01 1.2 0.99-1.4 .06
Age <60 yearsa 1.2 0.9-1.7 .1 1.5 0.99-2.2 .07 1.3 1.04-1.7 .03
Redo CEA 3.3 1.03-10.6 <.05 2.4 0.3-17.2 .4 3.0 1.1-8.2 .04
Hx of stroke/hemiplegia 1.9 1.5-2.3 <.001 2.3 1.7-3.1 <.001 2.0 1.7-2.4 <.001
Hx of TIA 1.4 1.2-1.8 <.01 1.5 1.1-2.1 <.01 1.5 1.2-1.7 <.001
Hx of angina/MI 1.6 1.04-2.4 .03 1.7 1.0-3.1 .06 1.6 1.2-2.3 <.01
Renal failure 1.0 0.4-2.2 .9 3.0 1.4-6.2 <.01 1.5 0.9-2.7 .1
Underweightb 2.3 1.3-4.1 <.01 0.9 0.3-2.9 .8 1.8 1.1-3.0 .03
Obesity class IIb 1.5 1.01-2.1 <.05 0.9 0.5-2.0 .6 1.3 0.9-1.7 .2
Functional status, dependentc 1.6 1.2-3.2 <.01 1.4 0.9-2.3 .2 1.7 1.3-2.2 <.001
Emergency procedure 1.9 1.1-3.2 .01 0.9 0.3-2.4 .8 1.5 0.99-2.5 .05
ASA class >3 1.4 1.1-1.8 .02 1.2 0.8-1.7 .4 1.3 1.1-1.6 .02
ASA, American Society of Anesthesiology; CEA, carotid endarterectomy; CI, conﬁdence interval;Hx, history;MI, myocardial infarction; OR, odds ratio; TIA,
transient ischemic attack.
Bold values indicate P < .05.
avs 60-70 years.
bvs normal weight.
cvs independent.
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predicted different endpoints, the cumulative effect of these
risk factors (female sex, renal failure, and COPD) is shown
in Table VIII (online only) for all different time points.
Patients undergoing emergency procedures were at
increased risk for all in-hospital events but not for post-
discharge events. All independent predictors for death
(Table V, online only), cardiac events (Table VI, online
only), and combined S/D/CE (Table VII, online only)
with respect to the different time intervals are available as
an online supplement.
DISCUSSION
In a large number of patients among both community
and academic institutions in the United States, CEA was
performed with very low complication rates for stroke,
death, or cardiac events (MI or cardiac arrest). Approxi-
mately one-third of procedural-related events occur after
discharge from the hospital. This was true for both patients
with prior neurologic symptoms and for those who were
asymptomatic. In this study, we identiﬁed predictors for
postdischarge events, which have not previously been re-
ported. We found that independent predictors for post-
discharge events but not for in-hospital events were female
sex (stroke and stroke/death), renal failure (stroke), and
COPD (death, stroke/death, and S/D/CE).
Previously, Sidawy et al4 described the occurrence
of adverse events happening after discharge but within
30 days of revascularization. For CAS, they found that
31% of combined strokes/deaths or MIs were not cap-
tured during hospital admission; for CEA, 28% of events
were missed when only analyzing in-hospital data. Al-
though less than one-half of patients in that analysis had
30-day follow-up, our results conﬁrm these estimates in
a 100% follow-up cohort. Most administrative vascular
registries do not include postdischarge events. The resultsof this study indicate that this may be a confounding
feature for many studies based on such datasets.1-3,10
It is well known that hospital administrative data are
not reliable to estimate nonfatal operative complication
rates for surgical procedures in general.11 Recently, the
reliability of administrative data to determine outcomes
speciﬁcally for carotid revascularization procedures was
questioned.9,12
Consistent entry of data beyond the in-hospital period
seems to be not only important for true perioperative event
risk estimation but also to identify patients at risk for
adverse perioperative events. Registries such as the NSQIP
are critical to evaluate rare events such as postoperative
stroke after CEA since single-surgeon or single-center
experiences are typically underpowered to evaluate proce-
dures with low event rates. Our results demonstrate that
in a subgroup of patients, adverse events are more likely
to happen after discharge, possibly inﬂuencing preoperative
counseling and perioperative management. The timing of
strokes suggests that some may be due to hyperperfusion
and subsequent intracerebral hemorrhage.13,14 Intracere-
bral hemorrhage occurs at unpredictable intervals in the
postoperative course and its mechanism remains unclear.
Previous analyses identiﬁed high-grade stenosis and
severe intra- or postoperative hypertension as possible risk
factors.13 Better blood pressure control and perhaps selec-
tive transcranial Doppler monitoring might beneﬁt these
patients.15 “Late” stroke might also occur due to thrombo-
embolism13 in patients who do not respond to antiplatelet
therapy. Preoperative testing for antiplatelet responsiveness
may identify subgroups at risk that may beneﬁt from addi-
tional antiplatelet medication. Unfortunately, the type and
laterality of postoperative stroke is not captured in the
NSQIP. Future research efforts should evaluate the mech-
anism of postoperative stroke to guide further changes in
perioperative management.
Table IV. Independent preoperative predictors for in-hospital, postdischarge, and 30-day stroke or death
In-hospital Postdischarge 30-day
OR 95% CI P value OR 95% CI P value OR 95% CI P value
Female 1.1 0.9-1.3 .4 1.4 1.1-1.7 <.01 1.2 1.03-1.4 .02
Age <60 yearsa 1.1 0.9-1.6 .2 1.4 0.96-1.9 .09 1.3 1.01-1.6 <.05
Age >80 yearsa 1.4 1.1-1.8 .01 1.3 0.9-1.9 .09 1.4 1.1-1.7 <.01
Hx of stroke/hemiplegia 1.8 1.5-2.2 <.001 2.0 1.5-2.5 <.001 1.9 1.6-2.2 <.001
Hx of TIA 1.3 1.04-1.5 .02 1.3 0.99-1.6 .05 1.3 1.1-1.5 <.01
Hx of angina/MI 1.9 1.4-2.7 <.001 1.6 1.1-2.6 .03 1.8 1.4-2.4 <.001
Renal failure 2.1 1.3-3.4 <.01 3.2 1.9-5.5 <.001 2.5 1.7-3.6 <.001
Hx of COPD 1.2 0.9-1.5 .3 1.8 1.4-2.4 <.001 1.4 1.2-1.7 <.01
Hx of PVD 1.5 1.1-2.0 <.01 1.3 0.9-1.9 .1 1.4 1.2-1.8 <.001
Functional status, dependentb 2.2 1.7- 2.9 <.001 1.6 1.2-2.4 <.01 2.0 1.6-2.5 <.001
Emergency procedure 2.7 1.8-3.9 <.001 0.6 0.2-1.5 .3 1.9 1.3-2.7 <.01
ASA class >3 1.6 1.3-2.0 <.001 1.3 0.99-1.8 .06 1.5 1.3-1.8 <.001
ASA, American Society of Anesthesiology; CI, conﬁdence interval; COPD, chronic obstructive pulmonary disease;Hx, history;MI, myocardial infarction; OR,
odds ratio; PVD, peripheral vascular disease, TIA, transient ischemic attack.
Bold values indicate P < .05.
avs 60-70 years.
bvs independent.
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happen more frequently after discharge. Studies based on
in-hospital results did not ﬁnd differences in stroke and
death rates after CAS and CEA in relation to sex.10,16
However, several others have also identiﬁed women as
a subgroup of patients at higher risk for 30-day adverse
outcome after CEA.6,17 Especially for asymptomatic
women, the beneﬁt of surgery may be less than that for
men.18,19 In our analyses, the difference between men
and woman in postdischarge events was identiﬁed for
both those with, and without a previous neurologic event,
although this did not quite reach statistical signiﬁcance for
asymptomatic patients. Sex differences in outcome of CEA
are still not well understood and merit further investiga-
tion.20,21 Renal failure was also an independent predictor
for postdischarge stroke but not for in-hospital or 30-
day stroke. Two studies based on NSQIP data6,22 found
that impaired renal function was an independent risk factor
for mortality and cardiac and pulmonary morbidity after
CEA, but was not associated with increased risk of neuro-
logic complications at 30 days, which was consistent with
our results. Also, other reports have suggested that renal
failure is a risk factor for increased stroke risk and a marker
for advanced atherosclerotic disease causing morbidity and
mortality.23-25
Several authors have reported risk factors associated
with adverse outcome after CEA to identify high-risk
groups and optimize management of patients with carotid
artery disease.5,6,18,26,27 Similar to prior reports, we found
that symptom status was a consistent predictor for adverse
events (both in-hospital and postdischarge), and that
a history of preoperative stroke was more predictive than
a history of TIA.27,28 Among other risk factors for only
in-hospital or both in-hospital and postdischarge out-
come, we identiﬁed several patient characteristics previ-
ously described by others, including diabetes26,27 and age>80 years.27,29 Interestingly, we found that patients with
redo CEA had increased risk for in-hospital stroke, whereas
others did not30,31 or only identiﬁed increased risk for local
complications such as cranial nerve injury.32 However,
these studies might not have detected a difference because
of low event rates and small sample sizes. Adequately pow-
ered studies are needed to deﬁne optimal treatment in
these patients. Under- and overweight patients had an
increased risk for stroke, suggesting that obesity is not
only a risk factor for mortality33,34 but also for morbidity
after CEA. This obesity paradox has been previously
identiﬁed with vascular surgery procedures with a reverse
J-shaped relation of BMI and adverse outcome, with the
highest risk in the underweight and morbidly obese
extremes, and the lowest rates in the overweight and mildly
obese patients.33-36 Not surprisingly and consistent with
previous literature,5,27,37 emergent procedures were pre-
dictive for all in-hospital adverse outcomes. This increased
risk was, however, not persistent after discharge. This is
understandable, as most emergent procedures would be
presumed to be performed for either stroke-in-evolution
or crescendo TIA.28,38
This study has several limitations. NSQIP does not
deﬁne preoperative symptom status in the same manner
as most clinical trials.6 Although a recent report from our
group showed that NSQIP does identify symptomatic
patients with a high sensitivity, the number of false-
positives was about 25% (because of stroke or TIA occur-
ring >6 months prior to surgery or contralateral to the
CEA).9 Therefore, we were only able to stratify the analysis
regarding timing of events for patients with and without
a previous neurologic event and accounted for these symp-
toms individually in multivariable prediction models.
However, importantly, we did not ﬁnd a difference in the
occurrence of postdischarge stroke in those who were
clearly asymptomatic compared with a group who had
JOURNAL OF VASCULAR SURGERY
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were likely within 6 months of and ipsilateral to their
CEA. Another limitation inherent to this database is the
lack of anatomical preoperative factors such as history of
previous neck radiation, degree of stenosis, or radical
neck dissection. Also, the retrospective nature of the data
may introduce a selection bias, which might have inﬂu-
enced the results. Because nonfatal cardiac events proved
to have a strong effect on patient survival, we included
cardiac events as one of our primary outcome measures.
Our deﬁnition of a cardiac event will capture both cardiac
arrest and new Q-wave MI on electrocardiogram but is
somewhat limited by the NSQIP database because patients
with ST-elevation MI (troponin leak) will be missed.
Lastly, CAS procedures are not yet included in the NSQIP
but will be in the future allowing comparison of the two
procedures.
CONCLUSIONS
With 38% of perioperative adverse events after CEA
happening posthospitalization, regardless of symptom
status, surgeons should be alert to the ongoing risks after
discharge particularly in women and patients with renal
failure or a history of COPD. For research and quality
improvement purposes, the full 30-day adverse event rates
should be reported and compared when evaluating CEA or
comparing CAS and CEA.AUTHOR CONTRIBUTIONS
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Appendix (online only). Deﬁnitions of preoperative variables.
Variable Deﬁnition
Hx of stroke/hemiplegia A history of a cerebrovascular accident (embolic, thrombotic, or hemorrhagic) with or without
persistent residual motor, sensory, or cognitive dysfunction. Acute or chronic neuromuscular
injury resulting in total or partial paralysis or paresis (weakness) of one side of the body.
Hx of TIA A history of focal neurologic deﬁcits (eg, numbness of an arm or amaurosis fugax) of sudden onset
and brief duration (usually <30 minutes) that usually reﬂects dysfunction in a cerebral vascular
distribution.
Hx of angina or MI A history of angina (pain or discomfort between the diaphragm and the mandible resulting from
myocardial ischemia) or myocardial infarction (MI, a non-Q wave or a Q wave infarct in the six
months prior to surgery) For patients on anti-anginal medications, only patients who had
angina within one month prior to surgery are included.
CHF Newly diagnosed CHF within the previous 30 days or a diagnosis of chronic CHF with new signs
or symptoms in the 30 days prior to surgery
Previous PCI A PCI at any time (including any attempted PCI). This includes either balloon dilatation or stent
placement.
Previous cardiac surgery Any major cardiac surgical procedures, includes coronary artery bypass graft surgery, valve
replacement or repair, repair of atrial or ventricular septal defects, great thoracic vessel repair,
cardiac transplant, left ventricular aneurysmectomy, insertion of LVADs, etc. Not include are
pacemaker insertions or AICD insertions.
Diabetes mellitus Diabetes mellitus with oral agents or insulin. The treatment regimen of the patient’s chronic,
long-term management.
Hypertension Persistent elevation of systolic blood pressure > 140 mm Hg or a diastolic blood pressure > 90
mm Hg or requires an antihypertensive treatment (eg, diuretics, beta blockers, ACE inhibitors,
calcium channel blockers) at the time the patient is being considered as a candidate for surgery
(which should be no longer than 30 days prior to surgery).
Current smoker Current smoker (cigarettes) within 1 year.
Hx of smoking If the patient has ever been a smoker, the total number of pack/years (number of packs of
cigarettes smoked per day times the number of years the patient has smoked) of smoking for
this patient is provided.
Alcohol use > 2 drinks/day The patient admits to drinking >2 oz of hard liquor or > two 12 oz cans of beer or > two 6 oz
glasses of wine per day in the two weeks prior to admission.
BMI BMI, calculated as weight (kg) divided by height (m2) <18.5 underweight, 18.5-24.9 normal
weight, 25-29.9 overweight, 30-34.9 obese class I, 35-40 obese class II, $40 obese class III
Renal failure Acute (steadily increasing azotemia [increase in BUN] and a rising creatinine of above 3 mg/dL
< 24 hours prior to surgery) or chronic renal failure requiring treatment with peritoneal
dialysis, hemodialysis, hemoﬁltration, hemodiaﬁltration, or ultraﬁltration within 2 weeks prior
to surgery.
Hx of COPD History of severe chronic obstructive pulmonary disease resulting in any one or more of the
following:
- Functional disability from COPD (eg, dyspnea, inability to perform ADLs)
- Hospitalization in the past for treatment of COPD
- Requires chronic bronchodilator therapy with oral or inhaled agents.
- An FEV1 of <75% of predicted on pulmonary function testing.
Patients are not included whose only pulmonary disease is asthma, an acute and chronic
inﬂammatory disease of the airways resulting in bronchospasm. Patients are not included
with diffuse interstitial ﬁbrosis or sarcoidosis.
Dyspnea Difﬁcult, painful, or labored breathing <30 days of surgery. Dyspnea may be symptomatic of
numerous disorders that interfere with adequate ventilation or perfusion of the blood with
oxygen
Steroid use If a patient requires regular administration of oral or parenteral corticosteroid medications (eg,
Prednisone, Decadron) in the 30 days prior to surgery for a chronic medical condition (eg,
COPD, asthma, rheumatologic disease, rheumatoid arthritis, inﬂammatory bowel disease).
Patients who only receive short course steroids (duration 10 days or less) in the 30 days prior
to surgery are not included
Hx of revascularization for PVD History of revascularization/amputation for PVD: any type of angioplasty (including stent
placement) or revascularization procedure for atherosclerotic PVD (eg, aorta-femoral, femoral-
femoral, femoral-popliteal) or a patient who has had any type of amputation procedure for PVD
(eg, toe amputations, transmetatarsal amputations, below the knee or above the knee
amputations). Patients who have had amputation for trauma or a resection of abdominal aortic
aneurysms should not be included.
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Appendix (online only). Continued.
Variable Deﬁnition
Restpain/gangrene Rest pain is a more severe form of ischemic pain due to occlusive disease, which occurs at rest and
is manifested as a severe, unrelenting pain aggravated by elevation and often preventing sleep.
Gangrene is a marked skin discoloration and disruption indicative of death and decay of tissues
in the extremities due to severe and prolonged ischemia. Patients included with ischemic
ulceration and/or tissue loss related to peripheral vascular disease. Fournier’s gangrene are not
included.
Functional status Functional health status prior to surgery <30 days. This variable focuses on the patient’s abilities
to perform activities of daily living.
Emergency procedure An emergency case is usually performed as soon as possible and no later than 12 hours after the
patient has been admitted to the hospital or after the onset of related preoperative
symptomatology.
ASA class > 3 The ASA Physical Status Classiﬁcation of the patient’s present physical condition on a scale from
1-5 as it appears on the anesthesia record.
ASA 1 - Normal healthy patient
ASA 2 - Patient with mild systemic disease
ASA 3 - Patient with severe systemic disease
ASA 4 - Patient with severe systemic disease that is a constant threat to life
ASA 5 - Moribund patient who is not expected to survive without the operation.
ACE, Angiotensin-converting-enzyme; AICD, automatic implantable cardioverter deﬁbrillator; ASA, American Society of Anesthesiologists; ADLs, Activities
of daily living; BMI, body mass index; BUN, blood urea nitrogen; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; FEV1, forced
expiratory volume in 1 second; Hx, history; LVADs, left ventricular assist devices; MI, myocardial infarction; PCI, percutaneous coronary intervention; PVD,
peripheral vascular disease; TIA, transient ischemic attack.
Table V (online only). Independent preoperative predictors for in-hospital, postdischarge, and 30-day death
In-hospital Postdischarge 30-day
OR 95% CI P value OR 95% CI P value OR 95% CI P value
Female 1.1 0.8-1.6 .7 1.2 0.8-1.7 .3 1.1 0.9-1.5 .3
Age >80 yearsa 2.5 1.5-4.2 <.001 2.4 1.5-3.8 <.001 2.4 1.7-3.5 <.001
Hx of stroke/hemiplegia 1.7 1.1-2.5 .01 1.7 1.2-2.5 <.01 1.7 1.3-2.2 <.001
Hx of angina/MI 2.8 1.6-4.7 <.001 1.1 0.5-2.2 .8 1.9 1.2-2.9 <.01
Renal failure 5.7 3.1-10.3 <.001 3.0 1.4-6.4 <.01 4.3 2.7-6.9 <.001
Hx of CHF 1.7 0.8-3.6 .2 2.0 0.9-4.5 .1 1.9 1.02-3.2 .04
Dyspnea 1.3 0.9-2.1 .2 1.7 1.1-2.5 <.01 1.5 1.2-2.0 <.01
Hx of COPD 1.4 0.9-2.3 .1 2.5 1.6-3.7 <.001 1.9 1.4-2.6 <.001
Hx of PVD 1.9 1.1-3.0 .01 1.8 1.2-2.8 .01 1.8 1.3-2.5 <.001
Functional status, dependent b 3.6 2.4-5.6 <.001 2.0 1.2-3.3 <.01 2.8 2.0-3.8 <.001
Emergency procedure 5.4 3.0-9.5 <.001 0.4 0.1-2.5 .3 2.9 1.7-4.8 <.001
ASA class >3 2.8 1.8-4.1 <.001 1.4 0.9-2.1 <.01 1.9 1.4-2.5 <.001
ASA, American Society of Anesthesiology; CHF, congestive heart failure; CI, conﬁdence interval; COPD, chronic obstructive pulmonary disease; Hx, history;
MI, myocardial infarction; OR, odds ratio; PVD, peripheral vascular disease, TIA, transient ischemic attack.
Bold values indicate P < .05.
avs 60-70 years.
bvs independent.
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Table VII (online only). Independent preoperative predictors for in-hospital, postdischarge, and 30-day stroke, death,
or cardiac events
In-hospital Postdischarge 30-day
OR 95% CI P value OR 95% CI P value OR 95% CI P value
Female 1.1 0.9-1.3 .2 1.2 0.97-1.5 .08 1.1 1.01-1.3 <.05
Age >80 yearsa 1.7 1.3-2.1 <.001 1.6 1.2-2.1 <.01 1.6 1.4-2.0 <.001
Redo CEA 3.2 1.3-8.0 .02 1.2 0.2-8.5 .9 2.4 1.04-5.7 .04
Hx of stroke/hemiplegia 1.7 1.4-2.0 <.001 1.7 1.4-2.2 <.001 1.7 1.5-1.9 <.001
Hx of TIA 1.2 0.9-1.4 .06 1.3 1.01-1.6 .04 1.2 1.1-1.4 <.01
Diabetes 1.2 1.03-1.4 .02 1.0 0.8-1.3 .7 1.2 1.01-1.3 .04
Hx of angina/MI 2.3 1.8-3.0 <.001 1.7 1.2-2.6 <.01 2.1 1.7-2.6 <.001
Renal failure 1.8 1.2-2.9 <.01 3.0 1.8-5.0 <.001 2.5 1.7-3.6 <.001
Hx of COPD 1.1 0.9-1.4 .4 1.8 1.4-2.3 <.001 1.3 1.1-1.6 <.01
Hx of PVD 1.5 1.2-1.9 <.01 1.3 0.98-1.8 .06 1.4 1.2-1.7 <.001
Functional status, dependentb 1.9 1.5-2.4 <.001 1.6 1.1-2.2 <.01 1.8 1.3-2.5 <.001
Emergency procedure 2.5 1.8-3.6 <.001 0.6 0.2-1.5 .3 1.8 1.3-2.5 <.001
ASA class >3 1.5 1.3-1.9 <.001 1.5 1.2-1.9 <.01 1.5 1.3-1.8 <.001
ASA, American Society of Anesthesiology; CEA, carotid endarterectomy; CI, conﬁdence interval; COPD, chronic obstructive pulmonary disease; Hx, history;
MI, myocardial infarction; OR, odds ratio; PVD, peripheral vascular disease, TIA, transient ischemic attack.
Bold values indicate P < .05.
avs 60-70 years.
bvs independent.
Table VI (online only). Independent preoperative predictors for in-hospital, postdischarge, and 30-day cardiac events
In-hospital Postdischarge 30-day
OR 95% CI P value OR 95% CI P value OR 95% CI P value
Female 1.1 0.8-1.4 .5 0.9 0.6-1.4 .7 1.0 0.8-1.3 .7
Race non-whitea 1.6 1.1-2.4 .01 1.2 0.6-2.2 .6 1.5 1.1-2.1 .02
Age >80 yearsb 2.7 1.8-3.8 <.001 2.0 1.2-3.3 <.01 2.4 1.8-3.3 <.001
Hx of stroke/hemiplegia 1.5 1.1-2.0 <.01 1.2 0.8-1.8 .3 1.4 1.1-1.8 <.01
Hx of angina/MI 3.4 2.3-5.0 <.001 1.9 0.9-3.6 .07 2.8 2.0-4.0 <.001
Diabetes 1.7 1.3-2.3 <.001 1.2 0.8-1.8 .4 1.5 1.2-1.9 <.001
Renal failure 2.1 1.1-4.1 .03 2.7 1.2-6.4 .02 2.3 1.3-3.9 <.01
Dyspnea 1.4 1.04-1.9 .02 1.6 1.02-2.4 .04 1.5 1.1-1.9 <.01
Hx of PVD 1.8 1.3-2.5 <.01 1.6 0.97-2.7 .07 1.7 1.3-2.3 <.001
ASA >3 1.6 1.2-2.2 <.01 2.2 1.4-3.3 <.001 1.8 1.4-2.3 <.001
Emergency 2.5 1.4-4.7 <.01 0.9 0.2-3.7 .9 2.0 1.1-3.5 .02
ASA, American Society of Anesthesiology; CI, conﬁdence interval; Hx, history; MI, myocardial infarction; OR, odds ratio; PVD, peripheral vascular disease.
Adjusted for sex.
Bold values indicate P < .05.
avs white.
bvs 60-70 years.
Table VIII (online only). Cumulative risk for stroke and stroke or death in the high-risk groups (female sex, renal
failure, and COPD)a for postdischarge events
Number of risk factors
Stroke Stroke/death
In-hospital Postdischarge 30-day In-hospital Postdischarge 30-day
0 1.0% 0.4% 1.4% 1.2% 0.7% 1.8%
1 1.2% 0.7% 1.9% 1.5% 1.1% 2.6%
2 0% 2.5% 2.5% 3.5% 5.0% 8.5%
3b 0% 0% 0% 4.3% 4.3% 8.7%
COPD, Chronic obstructive pulmonary disease.
Bold values indicate P < .05.
aHigh-risk group based on the independent predictors identiﬁed for postdischarge events by multivariable models.
bTwenty-three patients with all three risk factors present.
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